For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Amphenol Corporation (APH) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-09): Designation Watch · Cairn score -9 (−100…+100 Quality+Value blend) · Quality 71 · Value -74 · Sentiment 11 (timing only, not weighted) · Composite fair value $128.01 vs $163.34 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Amphenol Corporation is a global designer, manufacturer, and marketer of high-technology interconnect, sensor, and antenna solutions. The company specializes in electrical, electronic, and fiber optic connectors, interconnect systems, sensor-based products, and coaxial and high-speed specialty cables used to transmit voice, video, and data in complex electronic systems. Amphenol’s products serve a broad range of end markets, including automotive, industrial automation, broadband communications, information technology and data communications, mobile devices and mobile networks, commercial aerospace, military, and defense. Its portfolio spans harsh-environment connectors, RF and fiber solutions, high-speed board-to-board and backplane interconnects, power distribution components, and diverse sensor technologies supporting performance, reliability, and miniaturization across applications. Amphenol sells globally through its own sales force, independent representatives, and electronics distributors, primarily to original equipment manufacturers that integrate its components into their systems. Founded in 1932 and headquartered in Wallingford, Connecticut, Amphenol today plays a central role in enabling modern electronic and communications infrastructure worldwide.
Earnings Schedule
Checked daily · calendar updated Aug 9| Print date | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | $1.19 | $1.35 +13.4% | — | — |
| Apr 29, 2026 | $0.95 | $1.06 +11.6% | — | — |
| Jan 28, 2026 | $0.94 | $0.97 +3.2% | — | — |
Green = beat the estimate, red = missed. An earnings print is the fastest way a thesis changes — our designations should be re-read after each one.
Recent SEC Filings
| Filed | Form | Document |
|---|---|---|
| Aug 6, 2026 | 4 | View |
| Aug 6, 2026 | 8-K | View |
| Aug 6, 2026 | SCHEDULE 13G/A | View |
| Aug 5, 2026 | 4 | View |
| Aug 5, 2026 | 144 | View |
| Aug 5, 2026 | 4 | View |
| Aug 5, 2026 | 4 | View |
| Aug 4, 2026 | 144 | View |
| Aug 4, 2026 | 144 | View |
| Aug 3, 2026 | 144 | View |
| Aug 3, 2026 | 144 | View |
| Aug 3, 2026 | 4 | View |
Filings link to the SEC’s EDGAR system. Annual/quarterly reports (10-K, 10-Q, 20-F) carry the full story; 8-K/6-K current reports are the fastest signal that something material happened.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 3.34
Total Equity: $13.51B
Shares: 1,277,500,000
Total Debt: $0.00
Cash: $11.13B
EBITDA: $6.79B
Total Debt: $0.00
Cash: $11.13B
Revenue: $23.09B
Revenue: $23.09B
Revenue: $23.09B
Total Equity: $13.51B
Tax Rate: 23.1%
Equity: $13.51B
Total Debt: $0.00
Cash: $11.13B
Current Liabilities: $6.80B
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $13.51B
Shares: 1,277,500,000
Shares: 1,277,500,000
CapEx: -$996.60M
Shares: 1,277,500,000
Stock Price: $163.34
Net Income: $4.27B
Industry Benchmarks
Income Statement (Annual)
Last updated: Jul 31, 2026 9:18am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $10.9B | $12.6B | $12.6B | $15.2B | $23.1B |
| Cost of Revenue | $7.5B | $8.6B | $8.5B | $10.1B | $14.6B |
| Gross Profit | $3.4B | $4.0B | $4.1B | $5.1B | $8.5B |
| Operating Expenses | $1.3B | $1.4B | $1.5B | $2.0B | $2.6B |
| Operating Income | $2.1B | $2.6B | $2.6B | $3.2B | $5.9B |
| Net Income | $1.6B | $1.9B | $1.9B | $2.4B | $4.3B |
| EBITDA | $2.5B | $3.0B | $3.0B | $3.7B | $6.8B |
| EPS | $2.66 | $3.19 | $3.23 | $2.01 | $3.51 |
| EPS (Diluted) | $2.54 | $3.06 | $3.11 | $1.92 | $3.34 |
Balance Sheet (Annual)
Last updated: Jul 31, 2026 9:18am (8d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.2B | $1.4B | $1.5B | $3.3B | $11.1B |
| Total Current Assets | $6.0B | $6.5B | $6.8B | $9.7B | $20.3B |
| Total Assets | $14.7B | $15.3B | $16.5B | $21.4B | $36.2B |
| Current Liabilities | $2.4B | $2.7B | $3.2B | $4.1B | $6.8B |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $8.3B | $8.2B | $8.1B | $11.6B | $22.7B |
| Total Equity | $6.4B | $7.1B | $8.4B | $9.9B | $13.5B |
| Retained Earnings | $4.3B | $5.0B | $5.9B | $7.1B | $9.9B |
Cash Flow (Annual)
Last updated: Jul 31, 2026 1:20am (9d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $2.2B | $2.5B | $2.8B | $5.4B |
| Capital Expenditure | -$360.4M | -$383.8M | -$372.8M | -$665.4M | -$996.6M |
| Free Cash Flow | $1.2B | $1.8B | $2.2B | $2.1B | $4.4B |
| Acquisitions (net) | -$2.2B | -$288.2M | -$970.4M | -$2.2B | -$3.8B |
| Net Debt Issued / (Repaid) | -$160.5M | -$4.5M | $339.2M | $2.6B | $8.5B |
| Dividends Paid | -$346.7M | -$477.4M | -$500.6M | -$595.1M | -$802.2M |
| Stock Buybacks | -$661.7M | -$730.5M | -$585.1M | -$689.3M | -$665.2M |
| Net Change in Cash | -$504.9M | $176.0M | $101.9M | $1.8B | $7.8B |
Growth Trends (YoY %)
Last updated: Jul 31, 2026 9:18am (8d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +16.1% | -0.5% | +21.3% | +51.7% |
| Gross Profit Growth | +18.4% | +1.4% | +25.8% | +65.7% |
| Operating Income Growth | +22.8% | -1.0% | +23.3% | +85.9% |
| Net Income Growth | +19.6% | +1.4% | +25.7% | +76.2% |
| EBITDA Growth | +19.1% | -0.4% | +25.7% | +82.1% |
Dividend History (Last 20)
Last updated: Jul 31, 2026 9:18am (8d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-23 | $0.25 | — | — | — |
| 2026-03-23 | $0.25 | — | — | — |
| 2025-12-16 | $0.25 | — | — | — |
| 2025-09-16 | $0.17 | — | — | — |
| 2025-06-17 | $0.17 | — | — | — |
| 2025-03-18 | $0.17 | — | — | — |
| 2024-12-17 | $0.17 | — | — | — |
| 2024-09-17 | $0.17 | — | — | — |
| 2024-06-18 | $0.11 | — | — | — |
| 2024-03-18 | $0.22 | — | — | — |
| 2023-12-18 | $0.22 | — | — | — |
| 2023-09-18 | $0.21 | — | — | — |
| 2023-06-16 | $0.21 | — | — | — |
| 2023-03-20 | $0.21 | — | — | — |
| 2022-12-19 | $0.21 | — | — | — |
| 2022-09-19 | $0.20 | — | — | — |
| 2022-06-17 | $0.20 | — | — | — |
| 2022-03-21 | $0.20 | — | — | — |
| 2021-12-20 | $0.20 | — | — | — |
| 2021-09-20 | $0.15 | — | — | — |
Insider Trading (Recent)
Last updated: Aug 4, 2026 12:15am (5d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-31 | NORWITT RICHARD ADAM | M-OptionExercise | 500,000.00 | $0.00 | $0 |
| 2026-07-31 | NORWITT RICHARD ADAM | M-OptionExercise | 186,104.00 | $0.00 | $0 |
| 2026-07-31 | NORWITT RICHARD ADAM | S-Sale | 500,000.00 | $161.57 | $80.8M |
| 2026-07-31 | NORWITT RICHARD ADAM | S-Sale | 186,104.00 | $162.27 | $30.2M |
| 2026-05-22 | WALTER LUC | A-Award | 108,809.00 | $0.00 | $0 |
| 2026-05-22 | Straub Peter | A-Award | 108,809.00 | $0.00 | $0 |
| 2026-05-22 | Silverman David M | A-Award | 70,690.00 | $0.00 | $0 |
| 2026-05-22 | NORWITT RICHARD ADAM | A-Award | 464,989.00 | $0.00 | $0 |
| 2026-05-22 | Lampo Craig A | A-Award | 133,161.00 | $0.00 | $0 |
| 2026-05-22 | Ivas Michael R. | A-Award | 51,134.00 | $0.00 | $0 |
| 2026-05-22 | Doherty William J | A-Award | 108,809.00 | $0.00 | $0 |
| 2026-05-22 | D'AMICO LANCE E | A-Award | 83,020.00 | $0.00 | $0 |
| 2026-05-22 | Wolff Anne Clarke | A-Award | 1,552.00 | $0.00 | $0 |
| 2026-05-22 | Singh Prahlad R. | A-Award | 1,552.00 | $0.00 | $0 |
| 2026-05-22 | Livingston Robert | A-Award | 1,552.00 | $0.00 | $0 |
| 2026-05-22 | Lane Rita S. | A-Award | 1,552.00 | $0.00 | $0 |
| 2026-05-22 | Lamba Sanjiv | A-Award | 1,552.00 | $0.00 | $0 |
| 2026-05-22 | Falck David P | A-Award | 1,552.00 | $0.00 | $0 |
| 2026-05-22 | Altobello Nancy A. | A-Award | 1,552.00 | $0.00 | $0 |
| 2026-05-20 | Lampo Craig A | J-Other | 41,203.00 | — | — |
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Narrative Economics
market-narrative step).
Claude Reading
Starting with the raw tape: Amphenol printed $7.62B in Q1 2026, up from $4.81B a year prior — 58% YoY revenue growth for a $200B market cap industrial. But net margin collapsed from 20.1% in Q3 2025 to 12.2% in the latest quarter while revenue accelerated. That's a $933M NI on $7.62B versus $1.25B on $6.19B two quarters earlier — net income actually *fell* 25% sequentially on a 23% revenue jump. Something structural happened: either a large dilutive acquisition closed (the Andrew/CommScope deal timing fits), a one-time charge, or genuine margin compression from mix shift. The models glossed over this. The synthesis engine's DCF spitting out $231 fair value is extrapolating peak-2025 margins (18.6% net) against Q1 2026 revenue — that's the wrong denominator. If steady-state net margin is 15% rather than 19%, forward earnings are $4.5B not $5.7B, and the "42% upside" evaporates.
The archetype call of "high-growth profitable" at 0.72 confidence is defensible on trailing numbers but misleading forward. Revenue CAGR of 35.6% is inflated by what looks like M&A-driven scale, not organic. The pre-flight tag "traditional" is more honest — this is a serial acquirer of connector businesses, and organic growth in a normal year is high-single-digits. At 48.9x P/E, 9x sales, and 27.7x EV/EBITDA, APH trades like a semiconductor pure-play, not a connector conglomerate. For context, TE Connectivity trades around 20x earnings and Molex is private but comps around similar multiples. The 2.4x P/E premium to peers requires you to believe AI datacenter interconnect is a durable APH-specific moat rather than a rising tide. Insider activity is stock awards, not open-market buys — the "Net Insider Buying" signal is misclassified; grants are compensation, not conviction.
The Market Narrative layer's claim that fundamentals "anchor entirely" and the story is "under-believed" is where I most sharply dissent from the model stack. A stock at 49x earnings, 15x book, and 9x sales is not trading at a cyclical trough — it's trading at a cycle peak with AI-infrastructure premium baked in. The bear story the narrative engine itself lays out (Chinese commoditization, capex pullback risk, customer concentration in a handful of hyperscalers) is exactly right and exactly what the 12.2% Q1 margin might be foreshadowing. The Market Forces layer got this right calling it "Neutral" with "implausible growth assumptions" — that directly contradicts the Synthesis verdict of undervalued. When two of your own models flatly disagree, the synthesis composite ($128 → adjusted $231) shouldn't be treated as signal; it's noise from methodology disagreement. The honest read of the composite is $128 fair value, which puts current $163 at ~27% *overvalued*, not 42% undervalued.
A careful contrarian would note: (1) the $11.13B cash pile with reported zero debt looks like a data error — APH historically carries $4-5B of long-term debt, so EV/EBITDA is likely understated; (2) ROIC of 1.9x (i.e., 189%?) is almost certainly a calculation artifact, not a real number, undermining the "quality" scoring; (3) revenue confidence tagged "adequate" with "decelerating quarterly trend" contradicts the 51.7% YoY headline — the deceleration is real if you look at the sequential margin compression rather than YoY revenue; (4) at 0.56% dividend yield and 18.8% payout ratio, this stock offers nothing to income investors and is entirely a capital-appreciation bet on continued multiple expansion from already-elevated levels. Fair value on normalized 15% net margins, 12% forward growth, and a peer-appropriate 25x multiple lands around $135-145. Current $163 is 12-20% rich, not 42% cheap. I'd revisit at $130 or after two more quarters clarifying whether the Q1 margin drop is one-time or the new baseline.
GPT Reading
What jumps out is that the business has clearly stepped up a level operationally, but the stock price already assumes that step-change is durable. Revenue went from $15.22B in 2024 to $23.09B in 2025, up 51.7%, while net income rose from $2.42B to $4.27B, up 76%. That is outstanding performance, and it was not just a one-quarter fluke: quarterly revenue climbed from $3.61B in mid-2024 to $6.44B by 4Q25, with net margins mostly running in a very strong 17%-20% range through 2025. Operating margin at 25.4% and free cash flow of $4.38B on $23.09B of sales confirm this is a genuinely high-quality franchise, not a low-margin volume chaser. The balance sheet also looks unusually clean, with $11.13B of cash and no stated debt, which gives management a lot of strategic freedom.
But the most recent quarter complicates the clean “compounder” narrative. 1Q26 revenue accelerated again to $7.62B, up 58% versus 1Q25, yet net income was only $933M, a 12.2% margin, versus 15.3% a year earlier and far below the ~19%-20% margins posted in the prior three quarters. That is a big enough drop that I would not hand-wave it away. Either the mix shifted sharply, acquisition accounting is muddying comparability, or underlying incremental profitability is weaker than the headline growth implies. The model calling this “high-growth profitable” is directionally right on the historical numbers, but it risks overweighting growth and underweighting the fact that the latest datapoint shows margin compression at the exact moment the valuation leaves no room for it. At $163.34, the stock trades at roughly 49x earnings, 9.0x sales, and 27.7x EV/EBITDA—multiples that belong to a software-like secular winner, not a connector and components company, however well run.
That is why I reject the “undervalued” synthesis. On trailing free cash flow, the stock is around 46x FCF ($200.95B market cap versus $4.38B FCF). On trailing earnings, it is near 47x-49x. Even if I generously assume 2026 net income annualizes above the 2025 level despite the 1Q26 margin dip—say $4.8B-$5.0B—this is still about 40x earnings for a company whose end markets, while attractive, remain exposed to capex cycles, inventory swings, and industrial demand resets. The huge multi-year CAGR figures also need skepticism because they are calculated off a lower base and likely reflect acquisition layering and a sharp cyclical rebound, not a pure organic trend that can persist. The stock may deserve a premium for execution, cash generation, and mission-critical products, but the current premium is extreme.
The best argument against my view is straightforward: maybe the market is right that Amphenol has crossed from “excellent cyclical manufacturer” into “scarce infrastructure enabler” for AI, electrification, aerospace, and high-speed connectivity, and maybe 2025 was not an aberration but the new base. If revenue can hold near a $28B-$30B annual run rate after the $7.62B quarter, and if net margin normalizes back to 17%-19%, earnings power could move quickly toward $5.5B+, making today’s multiple compress faster than it appears. The no-debt balance sheet, 31.6% ROE, nearly 3.0x current ratio, and long record of converting earnings into cash are exactly the traits investors should pay up for. I also would not read much into the insider line items; these are awards, not open-market conviction buys or sells. A smart bull would say this is simply what a best-in-class consolidator looks like when secular demand inflects.
What would change my mind is simple: if the next two quarters show revenue staying above $7B while net margin recovers back above 17%, then I would accept that 1Q26 was a temporary distortion and that earnings power is materially higher than 2025’s $4.27B. Conversely, if revenue remains strong but margins stay in the low teens, the market’s current valuation is indefensible. For me to turn constructive at this price, I need proof that growth is not being bought at sharply lower incremental profitability. Absent that, fair value looks much lower—closer to a high-20s to low-30s earnings multiple on a $4.8B-$5.0B earnings base, which points more toward roughly $110-$130 than $163.
Grok Reading
Amphenol just printed a year that industrial compounders almost never print: revenue from $15.22B to $23.09B (+51.7%), net income from $2.42B to $4.27B (+76%), free cash flow of $4.38B on only $997M of capex, and a balance sheet carrying $11.13B cash against zero reported debt. The quarterly tape is even more aggressive—Q1 2026 revenue hit $7.62B, up roughly 58% from the $4.81B year-ago quarter and still accelerating sequentially from $6.44B. That is not a mature connector cycle; that is AI data-center, interconnect, and electrification content ramping through a company that has spent decades buying and integrating niche interconnect franchises. Operating margin held at 25.4% for the full year and ROE sits at 31.6%, so the growth is arriving with real economic returns, not just top-line optics. At $163.34 the stock trades 48.9x trailing earnings, 9.0x sales and 27.7x EV/EBITDA—expensive on the face of it, but against a business whose earnings CAGR over the measured window is nearly 49% and whose cash conversion is pristine, the multiple is less absurd than a static screen suggests.
The number that stops the celebration is Q1 2026 net margin collapsing to 12.2% ($933M of NI on $7.62B of revenue) after four consecutive quarters between 15% and 20%. Revenue exploded and profit fell. Until that is explained—acquisition step-up, mix, one-time tax or restructuring—it is the single most important data point in the set, because a sustained mid-teens net margin on a $30B+ run-rate re-rates the earnings power materially lower and leaves the 49x multiple looking stretched rather than prepaid growth. The “net insider buying” signal is also noise: every print on the tape is an A-Award dated the same day, i.e., compensation grants, not open-market accumulation. And the secondary flag that quarterly revenue trend is decelerating, while not yet visible in the absolute dollars, is a reminder that 50%+ growth off a $23B base is historically brief.
The strongest case against owning this here is straightforward multiple math plus cyclicality. A 49x P/E and 27.7x EV/EBITDA already discount several more years of mid-20s-or-better earnings growth; any pause in hyperscaler capex, a telecom inventory digestion, or Chinese pricing pressure in commoditizing connector categories would compress both the multiple and the growth rate simultaneously. The valuation engine’s own $231 composite sits in tension with its admission that “methods disagree” and that the market is already pricing more growth than base projections—exactly the setup that produces 30–40% drawdowns when a single quarter misses. Macro headwinds are flagged, customer concentration in large cloud and auto OEMs is real, and Amphenol has never been immune to industrial downcycles even if the current mix is more secular than it was a decade ago. A skeptic would say you are paying peak-cycle scarcity pricing for a company whose net margin just halved sequentially.
I would flip to a clear overvalued stance if the next two quarters show net margins stuck in the low teens without a credible bridge back to the high-teens/20% zone, or if sequential revenue growth rolls over below mid-single digits while the multiple stays above 40x forward. Conversely, two clean quarters of 18%+ net margins on a still-rising revenue base, or evidence that the Q1 compression was purely deal-related and non-recurring, would justify leaning harder into the undervaluation case and treating $163 as a gift relative to mid-$200s intrinsic value.
Big-3 Panel — where each AI stands
Claude — Second Response · overvalued held
VERDICT: Holding overvalued at $163; fair value $140-150 on normalized 15-16% margins and peer-appropriate 28-32x multiple; revisit only if Q2/Q3 2026 print >17% net margin on sustained $7B+ revenue.
GPT's reading essentially arrived at my conclusion by a different route — same skepticism on the 12.2% Q1 margin, same rejection of the synthesis "undervalued" verdict, same fair value band ($110-130 vs my $135-145). The convergence there is reinforcing, not moving. The interesting argument is Grok's, because Grok saw the same margin collapse I did and still landed at $200-220 fair value by treating Q1 as likely deal-related noise and anchoring on run-rate revenue with normalized margins. That's the bull case stated honestly, and I want to engage it rather than dismiss it.
Here's what didn't move me: Grok's fair value math requires *both* that Q1 margin compression is transitory *and* that a $30B revenue run-rate is durable. Those are two independent bets, each maybe 60-70% likely, and the joint probability is closer to 40-50% — not high enough to justify paying 49x trailing when the downside case (structural margin reset to 13-15%) implies $110-120. Asymmetry favors the skeptic here. Grok also concedes the exact tripwire I'd use — "flip to overvalued if next two quarters show margins stuck in low teens" — which means we agree on the test, we just disagree on the prior. Given that the *most recent* datapoint is the low-teens print, the correct Bayesian prior is skepticism until proven otherwise, not the reverse.
What genuinely gave me pause: Grok's point that $4.38B FCF on $997M capex is real cash, not accrual accounting, and cash conversion that clean is hard to fake with acquisition noise. That tempers my confidence that the Q1 margin drop reflects underlying deterioration rather than deal accounting — it's more likely a step-up amortization or transaction charge than genuine economic compression. I'll acknowledge that pushes my fair value band up modestly, toward $140-150 rather than $135-145. But it doesn't close the gap to $163, and it certainly doesn't get me to Grok's $200+. I'm holding overvalued with slightly reduced conviction, and the falsification test is explicit: two quarters of 17%+ net margin on $7B+ revenue and I revise.
GPT — Second Response · overvalued revised
VERDICT: Still overvalued at $163; elite franchise and possible secular re-rating, but until margins recover from 12.2% toward 17%+, fair value is roughly $130-$145.
Claude’s critique largely reinforces my original view rather than moving me off it. The strongest point he adds is not “AI premium is excessive” — I already thought that — but that the apparent net-cash/zero-debt picture may be a data artifact, which would make the EV-based valuation look slightly less flattering and weaken part of the “fortress balance sheet” comfort. More importantly, he sharpened the core inconsistency: if you annualize the bigger revenue base but continue to use 2025’s ~19% net margin, you are effectively importing peak profitability into a quarter that printed 12.2%. That is exactly the hidden assumption I was resisting. I also agree the insider “buying” is non-informative compensation noise. None of that changes my direction; it modestly increases conviction.
Grok’s pushback is the only thing that gave me pause, specifically the argument that APH may have structurally migrated from a cyclical connector roll-up into a scarcer AI/electrification interconnect platform, which could make static peer comps too conservative. If the company can hold something like a $28B-$30B revenue run-rate and recover margins into the high teens, today’s multiple would compress quickly and my prior $120-$130 range could prove too harsh. That said, the argument still depends on a margin normalization we have not yet seen. The latest quarter is not a small wobble; it is a material break in incremental profitability at the exact moment the stock is priced for excellence. So I am revising only in degree, not direction: I’ll concede the quality/secular mix may justify a somewhat higher fair range than my first pass, but not enough to make $163 attractive before the margin bridge is proven.
Grok — Second Response · overvalued changed direction
VERDICT: Elite franchise but modestly overvalued at $163; fair value $140-155 until margins prove they can re-expand above mid-teens
The colleagues’ sharp focus on the Q1 margin break forces a recalibration. Both correctly note that net income fell 25% sequentially even as revenue jumped 23% to $7.62B, dropping the net margin to 12.2% from the prior 19-20% band; Claude’s observation that any DCF still extrapolating 18-19% margins against the new revenue base is simply invalid is decisive. GPT’s parallel math—that even a generous $4.8-5.0B forward earnings leaves the stock at ~40x—lands harder than my original “if margins normalize” framing. I underweighted how quickly the multiple becomes indefensible if the compression is mix- or acquisition-driven (Andrew/CommScope timing fits) rather than purely temporary. Peer context seals it: TE Connectivity at ~20x makes the 49x premium look like peak AI-infrastructure scarcity pricing, not prepaid compounder economics.
I still reject the lower $120-130 fair-value anchors as too punitive; the fortress FCF conversion, 25%+ operating margins on the full-year base, zero-debt (or near-zero) balance sheet, and genuine AI/electrification content ramp remain elite and justify a structural premium over traditional connector peers. But the burden of proof has flipped: two clean quarters of margin recovery above 17% on a $28B+ run-rate would restore the $200 path; absent that evidence the current tape already prices perfection. The insider “buying” noise and any ROIC artifacts further weaken the quality overlay I originally leaned on. Net result is a clear revision away from modest undervaluation.
Advanced Analysis Forensic deep-dive · three lenses
The operating business is firing on all cylinders: revenue grew from $10.88B (2021) to $23.09B (2025), a ~21% CAGR, while gross margin expanded from 31.3% to 36.9% and operating margin from 19.4% to 25.4% - textbook operating leverage in electronic components/interconnect. Net income more than doubled from $1.90B (2022) to $4.27B (2025), and FCF of $4.38B in 2025 essentially matches net income (OCF/NI 1.17x, accruals -2% of assets, Beneish -2.38, Altman Z 7.3). Liquid cash of $11.43B against zero net debt gives a fortress balance sheet.
Verify before trusting this (5)
- Confirm the 2024 diluted share jump from 620M to 1.28B is the 2-for-1 stock split, not real dilution
- Segment mix of the 2025 revenue surge - how much is AI/datacenter interconnect vs core industrial/auto
- Customer concentration disclosure in the 10-K, particularly hyperscaler exposure
- Acquisition contribution to 2025 growth (Amphenol is a serial acquirer - CIT deal etc.) vs organic
- 10b5-1 plan disclosures behind the $130M of insider sales
At $163.34 versus a composite fair value of $128.38, APH trades roughly 27% above deserved value. The DCF pins it at $116 and the EPV floor at just $31 - both saying the current price already capitalizes years of continued compounding. The only method supporting the tape is the anchored P/E at $175.50, which reflects the market's willingness to pay a premium multiple for a proven serial compounder. The signal-adjusted $231.93 fair value implies 42% upside but is essentially the composite stretched by momentum/quality overlays; treating it as gospel would be a mistake when the underlying DCF is $47 lower than the current price. Quality is genuinely strong (score 71) and earnings quality is high, so I raise deserved value above the raw composite - call it somewhere in the $135-150 zone. Even generously, $163 is a full-to-rich price, not a discount. The bear case (commoditization, capex pullback, China pressure) is not priced in at all; the bull case (electrification, AI datacenter connectors, disciplined M&A) largely is. Margin of safety is negative. This is the classic 'great business, wrong price' setup - the market already knows APH is excellent, and you are paying for that knowledge.
Verify before trusting this (4)
- Confirm the 2024 stock split accounts for the diluted share count jump so per-share math is clean
- Forward organic growth guidance vs the mid-single-digit DCF assumption
- AI/datacenter connector mix and incremental margins in the latest segment disclosure
- M&A pipeline commentary and multiples paid - key to the compounder thesis holding
The tape is nominally risk-on (regime +34, VIX 15.9), which at beta 1.24 would normally be a modest tailwind for APH. But the narrative engine is essentially off: intensity is minimal, archetype is 'quiet-quality,' and cult coefficient is low. Nothing is actively pulling this name up the way AI-infrastructure stories are dragging peers like Vertiv higher. The news flow around the connector/data-center complex is mixed - VRT rips on AI capex, GLW bleeds on the same theme - and APH is not the market's chosen vehicle for either side of that trade. That absence of a story is itself a soft headwind in a tape where narrative-led names get the bid. Offsetting that, momentum is strong (recent 51.7% vs 35.6% long-term CAGR), which tells you positioning is not broken and the quiet compounder bid is still there. Macro sensitivity is mild negative (10y 4.75%, market PE 26.9), but APH's diversified industrial mix and profitability make it far less exposed than the speculative cohort. Net: forces roughly cancel. A risk-on tape and healthy momentum against a story-vacuum and a market that is rewarding louder AI names elsewhere.
Verify before trusting this (4)
- Whether analyst target revisions post next earnings tilt positive on AI/data-center exposure - could shift APH into the narrative winners bucket
- Any sector rotation out of AI-infra winners (VRT, ANET) that could rotate into quieter connector plays
- VIX break above 20 or regime flip to risk-off - would hit the 1.24 beta harder than the tape suggests today
- Guidance tone on telecom/data-center capex - the bear case hinges on a capex pullback
Character & Durability Scorecard
Survivability 8/10
Fortress balance sheet with substantial net cash and consistently positive FCF through the pandemic period demonstrates strong resilience, though lacks evidence of multiple severe downturns.
- Net cash position of $11.43B with Altman Z-score of 7.3 (safe zone)
- FCF remained positive through 2020-2025 period, growing from $1.18B to $4.38B
Adaptability 8/10
Company has demonstrated strategic pivots across end markets over decades and recent margin expansion suggests successful portfolio mix shift toward higher-value segments.
- Revenue mix shift visible in margin expansion from 31.3% to 36.9% GM over 4 years
- Amphenol historically pivoted from military/aerospace to diversified interconnect solutions across automotive, industrial, IT/datacom
Moat Trajectory 8/10
Widening margins during rapid growth indicate strengthening pricing power and competitive position, characteristic of an expanding moat in mission-critical components.
- Gross margin expanded 560 bps from 31.3% to 36.9% over 4 years while revenue doubled
- Electronic connector industry has high switching costs due to design-in cycles and custom engineering
Capital Allocation 7/10
Heavy use of equity for M&A but margin expansion and FCF growth suggest acquisitions have been accretive, though dilution of 19.6% annually is a significant offset.
- Share count doubled from 625M to 1.28B (2021-2025), indicating major M&A activity
- FCF compounded at 39% CAGR while operating margin expanded 600 bps, suggesting accretive acquisitions
Pricing Power 9/10
Sustained margin expansion through a period of inflation and rapid growth demonstrates strong pricing power without volume loss.
- Gross margin expanded from 31.3% to 36.9% during 2021-2025
- Operating margin improved from 19.4% to 25.4% while revenue more than doubled
Management Alignment 6/10
Mixed signals with low SBC burden and some insider buying offset by heavy insider selling, suggesting moderate rather than exceptional alignment.
- Net insider buying present but 7 sells ($130.8M) vastly outweigh 1 buy ($1.3M)
- SBC at only 0.6% of revenue suggests reasonable compensation discipline
Demand Durability 8/10
Strong secular tailwinds from electrification, datacenter expansion, and rising electronic content across industrial and automotive applications drive durable multi-year demand.
- Electronic interconnect content per device rising with electrification, 5G, AI/datacenter build-out
- Revenue doubled from $10.88B to $23.09B over 4 years
Growth Consistency 7/10
Strong overall growth trajectory with one flat year (2023) but FCF compounded consistently and acceleration in 2024-2025 shows solid delivery despite some lumpiness.
- Revenue grew 16%, -1%, 21%, 52% in successive years (2021-2025)
- FCF grew steadily: $1.18B, $1.79B, $2.16B, $2.15B, $4.38B
Optionality / Runway 8/10
Multiple credible expansion pathways across electrification, AI infrastructure, and emerging connectivity standards provide substantial embedded optionality beyond the current $23B base.
- Electrification of transportation and industrial equipment creates decades-long content expansion runway
- Datacenter/AI infrastructure build-out provides additional growth vector beyond core automotive/industrial
Concentration / Key-Person Risk —
Cannot assess customer or product-line concentration without segment detail, though electronic components industry typically has diversified customer bases.
- No customer concentration or segment revenue breakout provided in the brief